Stephen J Nicholls Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

10/2022	Optical coherence tomography in coronary atherosclerosis assessment and intervention.
2/2022	Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.
1/2022	Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
1/2022	Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
1/2022	Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction.
1/2022	Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician.
1/2022	Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications.
10/2021	Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
1/2021	Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease.
1/2021	Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Nicholls Research Topics

Disease

97	Atherosclerotic Plaque (Atheroma) 12/2022 - 08/2005
97	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 10/2004
70	Atherosclerosis 03/2022 - 10/2004
65	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2005
40	Myocardial Infarction 12/2022 - 07/2007
34	Acute Coronary Syndrome 12/2022 - 01/2008
31	Inflammation (Inflammations) 01/2022 - 06/2005
26	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2006
23	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2007
22	Stroke (Strokes) 03/2022 - 09/2007
21	Disease Progression 02/2021 - 04/2006
16	Heart Failure 11/2021 - 09/2007
14	Dyslipidemias (Dyslipidemia) 03/2022 - 03/2007
14	Unstable Angina 03/2022 - 11/2012
12	Thrombosis (Thrombus) 10/2022 - 08/2006
12	Vascular Diseases (Vascular Disease) 10/2020 - 09/2007
10	Hypertension (High Blood Pressure) 02/2022 - 06/2006
10	ST Elevation Myocardial Infarction 01/2022 - 08/2013
10	Diabetes Mellitus 01/2021 - 01/2010
9	Hypertriglyceridemia 12/2020 - 05/2010
8	AIDS-Related Complex (ARC) 02/2022 - 08/2014
6	Ischemia 11/2019 - 03/2014
6	Pathologic Constriction (Stenosis) 08/2018 - 11/2006
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 04/2008
5	Hemorrhage 01/2022 - 01/2018
4	Hypoxia (Hypoxemia) 03/2022 - 01/2018
4	Rupture 01/2022 - 08/2013
4	Hyperlipidemias (Hyperlipidemia) 01/2022 - 11/2011
3	Hypercholesterolemia 01/2021 - 03/2007
3	Chronic Renal Insufficiency 11/2019 - 05/2013
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2019 - 01/2017
3	Obesity 01/2018 - 06/2006
3	Coronary Stenosis (Coronary Artery Stenosis) 10/2010 - 08/2006
2	COVID-19 01/2021 - 07/2020
2	Injection Site Reaction 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

69	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2005
58	LipidsIBA 12/2022 - 12/2005
46	LDL CholesterolIBA 03/2022 - 02/2007
37	HDL CholesterolIBA 03/2022 - 02/2007
36	oxidized low density lipoproteinIBA 01/2022 - 01/2006
26	Atorvastatin (Lipitor)FDA Link 01/2022 - 11/2005
25	HDL LipoproteinsIBA 01/2022 - 08/2005
24	Triglycerides (Triacylglycerol)IBA 03/2022 - 03/2007
24	Lipoproteins (Lipoprotein)IBA 03/2022 - 02/2007
22	Rosuvastatin Calcium (Crestor)FDA Link 11/2019 - 04/2006
21	CholesterolIBA 02/2022 - 06/2005
21	C-Reactive ProteinIBA 01/2022 - 06/2006
17	omega-Chloroacetophenone (Mace)IBA 03/2022 - 05/2010
15	Cholesterol Ester Transfer ProteinsIBA 01/2022 - 06/2005
13	evacetrapibIBA 01/2022 - 11/2011
12	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 05/2007
11	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2008
11	CalciumIBA 10/2021 - 01/2007
11	apabetaloneIBA 01/2021 - 03/2011
11	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 02/2007
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2007
9	Lipoprotein(a)IBA 01/2022 - 08/2017
9	evolocumabIBA 01/2022 - 06/2016
9	Peroxidase (Myeloperoxidase)IBA 02/2014 - 10/2004
8	ApolipoproteinsIBA 01/2020 - 02/2007
7	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 04/2012
7	Biological ProductsIBA 01/2021 - 01/2005
5	Insulin (Novolin)FDA Link 02/2022 - 04/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2007
5	aleglitazarIBA 01/2020 - 09/2013
5	Phenobarbital (Luminal)FDA Link 01/2020 - 03/2006
4	TicagrelorIBA 01/2022 - 01/2018
4	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2018
4	Ezetimibe (Zetia)FDA Link 01/2022 - 09/2013
4	empagliflozinIBA 11/2021 - 10/2020
4	Apolipoproteins B (ApoB)IBA 12/2020 - 01/2016
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 09/2013
4	PCSK9 InhibitorsIBA 01/2019 - 06/2016
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2018 - 11/2014
4	Pioglitazone (Actos)FDA Link 07/2015 - 09/2007
4	Oxidants (Oxidizing Agents)IBA 03/2010 - 10/2004
3	torcetrapibIBA 01/2022 - 03/2007
3	Proprotein Convertase 9IBA 02/2021 - 12/2016
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2020
3	dalcetrapibIBA 01/2020 - 11/2012
3	Nonesterified Fatty Acids (NEFA)IBA 01/2018 - 03/2013
3	CER-001IBA 01/2018 - 02/2017
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2021
2	Sodium-Glucose Transport ProteinsIBA 10/2021 - 10/2020
2	Corn Oil (Oil, Corn)IBA 05/2021 - 12/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2021 - 08/2006
2	TroponinIBA 01/2021 - 03/2010
2	Olive OilIBA 01/2021 - 09/2013
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2021

Therapy/Procedure

102	Therapeutics 12/2022 - 06/2005
8	Percutaneous Coronary Intervention 10/2022 - 07/2012
6	Stents 10/2022 - 01/2018
6	Secondary Prevention 01/2022 - 08/2019
5	Transcatheter Aortic Valve Replacement 05/2022 - 08/2016
4	Drug-Eluting Stents 10/2022 - 07/2012
4	Glycemic Control 03/2022 - 09/2007
4	Thrombolytic Therapy 01/2022 - 01/2018
3	Cardiac Rehabilitation 02/2022 - 04/2019
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2014